Release Date: 28/09/11 09:19 Summary: Bullabulling Additional Prospecting Licences Price Sensitive: Yes Download Document 177.55KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%